Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-004738-33Phase 4Completed
Phase 4 trial of alendronate, ibandronate and risedronate in osteoporosis (3 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in heel broadband ultrasound attenuation (BUA). Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-004738-33.